TD Private Client Wealth LLC Has $2.91 Million Stake in iShares Biotechnology ETF $IBB

TD Private Client Wealth LLC boosted its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 164.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,225 shares of the financial services provider’s stock after acquiring an additional 10,717 shares during the period. TD Private Client Wealth LLC’s holdings in iShares Biotechnology ETF were worth $2,907,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Darwin Wealth Management LLC acquired a new position in iShares Biotechnology ETF during the 2nd quarter worth $25,000. Cornerstone Planning Group LLC acquired a new position in iShares Biotechnology ETF during the 4th quarter worth $35,000. Strategic Wealth Advisors LLC acquired a new position in iShares Biotechnology ETF during the 4th quarter worth $35,000. Parkside Financial Bank & Trust lifted its position in iShares Biotechnology ETF by 48.6% during the 3rd quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock worth $38,000 after acquiring an additional 87 shares during the last quarter. Finally, Close Asset Management Ltd lifted its position in iShares Biotechnology ETF by 25.5% during the 3rd quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock worth $50,000 after acquiring an additional 70 shares during the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $164.03 on Tuesday. iShares Biotechnology ETF has a fifty-two week low of $119.78 and a fifty-two week high of $179.64. The firm has a fifty day moving average price of $169.14 and a two-hundred day moving average price of $169.70.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were given a dividend of $0.1218 per share. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $0.49 dividend on an annualized basis and a dividend yield of 0.3%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.